ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 351710 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 351710; 2) Community: the network communities that were significantly associated with the response to NSC 351710; 3) Molecule: the relationships between components within communities and NSC 351710; 4) MDR: the compounds that were significantly associated with the NSC 351710.

NSC Compound Enrichment Correlation
NSC 692655 D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate 0.0361455178924426 -0.022460993
NSC 752330 6-(2-(propan-2-ylidene)hydrazinyl)-9H-purine-9-beta-D-riboside 0.0361455178924426 -0.18934637
NSC 29459 Quinoline, 4-[.alpha.-[bis(2-chloroethyl)amino]-4-methoxy-m-toluidino]-7-chloro-, dihydrochloride 0.0361455178924429 0.1218867
NSC 622700 Methanaminium, (2-oxo-1,3-cyclohexanediyl)bis(methyl)bis [N,N,N-trimethyl-, diiodide 0.036145517892443 -0.29645928
NSC 630684 8-Quinolinecarboxaldehyde, 2-(2,4-dinitrophenyl)-2-methyl- hydrazone 0.036145517892443 0.37676521
NSC 173516 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride 0.0376362543535812 0.15907286
NSC 207895 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0376362543535812 0.085804335
NSC 255105 GELDANAMYCIN ANALOG 0.0376362543535812 -0.32772703
NSC 380721 Eremantholide B 0.0376362543535815 -0.24900479
NSC 46213 Null 0.0376362543535815 0.27866825
Total:37  Current:26    [First] [Prev] [Next] [Last]